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Abstract
Background—Before 2007, U.S.-bound immigrants and refugees were screened for tuberculosis 
(TB) by a smear-based algorithm that could not diagnose smear-negative and culture-positive TB. 
In 2007, the Centers for Disease Control and Prevention began to implement a culture-based 
algorithm.
Objective—To evaluate the effect of the culture-based algorithm on preventing the importation 
of TB to the United States by immigrants and refugees from foreign countries.
Design—Population-based, cross-sectional study.
Setting—Panel physician sites for overseas medical examination.
Patients—Immigrants and refugees with TB.
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Measurements—Comparison of the increase of smear-negative and culture-positive TB cases 
diagnosed overseas among immigrants and refugees by the culture-based algorithm with the 
decline of reported TB cases among foreign-born persons within 1 year after arrival in the United 
States from 2007 to 2012.
Results—Of the 3 212 421 arrivals of immigrants and refugees from 2007 to 2012, 1 650 961 
(51.4%) were screened by the smear-based algorithm and 1 561 460 (48.6%) were screened by the 
culture-based algorithm. Among the 4032 TB cases diagnosed by the culture-based algorithm, 
2195 (54.4%) were smear-negative and culture-positive. Before implementation (2002 to 2006), 
the annual number of reported TB cases among foreign-born persons within 1 year after arrival 
was relatively constant (range, 1424 to 1626 cases; mean, 1504 cases) but decreased from 1511 to 
940 cases during implementation (2007 to 2012). During the same period, the annual number of 
smear-negative and culture-positive TB cases diagnosed overseas among U.S.-bound immigrants 
and refugees by the culture-based algorithm increased from 4 in 2007 to 629 in 2012.
Limitation—This analysis did not control for the decline in new arrivals of nonimmigrant visitors 
to the United States and the decrease of incidence of TB in their countries of origin.
Conclusion—Implementation of the culture-based algorithm in U.S.-bound immigrants and 
refugees may have substantially reduced the incidence of TB among newly arrived, foreign-born 
persons in the United States.
Primary Funding Source—None.
Immigration has a substantial effect on the incidence of tuberculosis (TB) in the United 
States (1, 2). In 2013, 6172 (64.4%) of the 9588 new TB cases reported in the United States 
were among foreign-born persons (3). To reduce the incidence of TB in the United States, 
U.S.-bound immigrants and refugees are required to have overseas TB screening (1). Before 
2007, overseas TB screening was limited to chest radiography and the use of a smear-based 
algorithm (acid-fast bacilli smears of 3 consecutive sputum samples from persons with 
abnormal chest radiographs) (4). Although smear-based screening for TB overseas with 
follow-up evaluation was a relatively high-yield intervention for preventing TB in U.S.-
bound immigrants and refugees (5, 6), studies showed a likely advantage of including the 
Mycobacterium tuberculosis culture in overseas screening (7, 8). Of 183 U.S.-bound 
immigrants in Vietnam whose M. tuberculosis culture was positive, 120 (65.6%) had a 
smear that was negative for acid-fast bacilli (7). Overseas screening with M. tuberculosis 
culture substantially reduced the TB incidence rate among newly arrived Hmong refugees in 
the United States (8).
In 2007, the Centers for Disease Control and Prevention (CDC) revised the smear-based 
screening algorithm to include the M. tuberculosis culture, drug-susceptibility testing, and 
directly observed therapy for TB treatment (9, 10). Because of the importance in identifying 
and treating latent TB infection (2), the new culture-based screening algorithm also required 
latent TB infection screening for persons aged 2 to 14 years in countries with a World 
Health Organization (WHO)–estimated incidence of TB of 20 cases or greater per 100 000 
persons per year. The culture-based algorithm was first implemented in Thailand (April 
2007) and then in Mexico, the Philippines, Belize, and Qatar (October 2007). It had been 
implemented in 81 countries as of December 2012 and in all countries in October 2013 (11).
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A recent study of newly arrived immigrants and refugees in California showed that fewer 
TB cases were imported from countries where the culture-based algorithm had been 
implemented (12). A preliminary analysis at the CDC showed that smear-negative and 
culture-positive TB accounted for approximately 60.0% of the 1100 TB cases diagnosed 
overseas among U.S.-bound immigrants and refugees by the culture-based algorithm in 2012 
(13). We analyzed a national data set from the CDC to evaluate the effect of implementing 
the culture-based algorithm in U.S.-bound immigrants and refugees from 2007 to 2012.
Methods
Study Population
The study population included immigrants and refugees who were initially screened for TB 
overseas between 2007 and 2012 and arrived in the United States before 1 May 2014, the 
date that we obtained the final data set for the analysis. Data about TB diagnoses from 
overseas screening and follow-up evaluation after arrival in the United States and about 
refugee arrivals were obtained from the CDC’s Electronic Disease Notification (EDN) 
database. Summary data of immigrant arrivals (by arrival year, birth country, sex, and age) 
came from the U.S. Department of Homeland Security. For comparison, we also obtained 
the annual number of reported TB cases among foreign-born persons within 1 year after 
arrival from the National Tuberculosis Surveillance System between 2002 and 2012 (14–
16).
Overseas TB Screening
Overseas medical examination is required for all U.S.-bound immigrants and refugees, and 
TB screening is a major component of the examination. Overseas medical examination is 
performed by 400 to 800 panel physicians, licensed local physicians who are appointed by 
the U.S. embassies and consulates (5, 17). The CDC provides technical guidance and 
oversight to the panel physicians. Before 2007, overseas TB screening was based on a 
smear-based algorithm that consisted of standard posteroanterior radiography of the chest 
for persons aged 15 years or older; in the case of persons with chest radiographs suggestive 
of active TB or with symptoms of TB, sputum specimens were collected on 3 consecutive 
days and stained for acid-fast bacilli (4). The smear-based algorithm classified persons as 
class A TB if chest radiographs were suggestive of active TB and 1 or more sputum smears 
were positive for acid-fast bacilli, class B1 TB if chest radiographs were suggestive of active 
TB and sputum smears were negative for acid-fast bacilli on 3 consecutive days, class B2 
TB if chest radiographs were suggestive of TB that was not clinically active (such as 
showing fibrosis, scarring, pleural thickening, diaphragmatic tenting, or blunting of 
costophrenic angles), or no TB if chest radiographs were normal (Table 1). Appendix Figure 
1 (available at www.annals.org) demonstrates the smear-based algorithm.
As a result of methodological research (7, 8), the CDC formally revised the smear-based 
algorithm in 2007 to include the M. tuberculosis culture for those identified with class B1 or 
B2 TB by the smear-based algorithm (9, 10). The new culture-based algorithm also required 
persons aged 2 to 14 years in countries with a WHO-estimated incidence of TB of 20 cases 
or greater per 100 000 persons per year to have screening for latent M. tuberculosis 
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infection. The culture-based algorithm classified persons as class A TB if chest radiographs 
were suggestive of TB disease and 1 or more sputum smears or mycobacterial cultures were 
positive, class B1 TB if chest radiographs were suggestive of TB disease and both sputum 
smears and mycobacterial cultures were negative, class B2 latent TB infection if chest 
radiographs were normal but the tuberculin skin test was 10 mm or greater or the interferon-
γ release assay was positive, or no TB if the person had no signs or symptoms of TB and 
chest radiographs were normal. For persons screened for latent TB infection, their tuberculin 
skin test or interferon-γ release assay results were negative (Table 1). Appendix Figure 2 
(available at www.annals.org) demonstrates the culture-based algorithm. Persons with class 
A TB had to complete overseas TB treatment, and directly observed therapy was required 
for those screened by the culture-based algorithm.
Persons could apply for an immigration waiver after their smears became negative (for those 
screened by smear-based algorithm) or both their smears and cultures became negative (for 
those screened by the culture-based algorithm) (4, 5, 10). Class A TB waivers were rare. The 
smear-based algorithm reclassified persons who completed overseas TB treatment as class 
B2 TB, and the culture-based algorithm reclassified persons who completed directly 
observed therapy for TB as class B1 TB (4, 10).
For persons diagnosed with TB disease overseas by the smear-based algorithm, their 
medical examination forms did not require panel physicians to provide information about 
their TB diagnosis and treatment. However, for those diagnosed with TB disease by the 
culture-based algorithm, the newly revised medical examination forms recorded their TB 
diagnosis and treatment. We classified persons who were diagnosed with TB disease by the 
culture-based algorithm and completed overseas TB treatment as smear-positive and culture-
positive TB, smear-positive and culture-negative TB, smear-negative and culture-positive 
TB, or clinically diagnosed TB. Because overseas drug-susceptibility testing was not 
systematically reported on the overseas medical examination forms between 2007 and 2012, 
we could not calculate prevalence of multidrug-resistant TB and study the pattern of drug 
resistance among U.S.-bound immigrants and refugees.
Follow-up Evaluation After Arrival in the United States
Persons with a class A TB waiver were mandated to report to health departments for follow-
up evaluation after arrival. Through its EDN database, the CDC notified state and local 
health departments about arriving immigrants and refugees identified with class B1 or B2 
TB by the smear-based algorithm and those identified with class B1 TB or class B2 latent 
TB infection by the culture-based algorithm. Health department physicians were asked to 
conduct a follow-up evaluation, assign a TB diagnosis after arrival, and complete the follow-
up evaluation worksheet (5). Follow-up evaluation data were entered into the CDC’s EDN 
database by state or local health departments.
Ethical Review
The study protocol was reviewed for human subject concerns by the CDC and found to be 
consistent with the CDC’s public health surveillance activities and not human subject 
research; therefore, review by an institutional review board was not required.
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Estimation of the Number of Immigrants Screened by the Culture-Based Algorithm [level 3] 
The CDC’s EDN database collected information about overseas medical examination for all 
refugees and immigrants with medical conditions. To estimate the number of immigrants 
screened by the culture-based algorithm from 2007 to 2012, we assumed that the number of 
immigrants screened overseas was equal to the number of immigrant arrivals during a 
specific year, and the number of immigrant arrivals was uniformly distributed by month 
within a specific year. For example, the implementation date was 1 October 2007 for 
Mexico and the number of Mexican immigrants screened by the culture-based algorithm 
was estimated as 25.0% of arrivals in 2007 (average arrivals in 3 months, October to 
December) and 100% of arrivals to 2008 to 2012.
Evaluation of the Effect of Implementing the Culture-Based Algorithm
We described the progress of implementing the culture-based algorithm and calculated the 
prevalence of TB for persons screened by the culture-based algorithm. We also calculated 
the proportions of active TB diagnosed among newly arrived immigrants and refugees with 
class B1 or B2 TB by follow-up evaluation in the United States.
Had the culture-based algorithm not been implemented, cases of smear-negative and culture-
positive TB among U.S.-bound immigrants and refugees would have been imported to the 
United States and would likely have been reported as TB cases among newly arrived, 
foreign-born persons in the U.S. National Tuberculosis Surveillance System. By applying 
the mean of the annual number of reported TB cases among foreign-born persons within 1 
year after arrival before implementation (2002 to 2006) as the baseline, we calculated the 
difference between the baseline and the annual number of reported TB cases among foreign-
born persons within 1 year after arrival during implementation (2007 to 2012). We 
compared the cumulative sum of the differences with the total number of smear-negative 
and culture-positive TB cases diagnosed overseas among U.S.-bound immigrants and 
refugees by the culture-based algorithm during implementation.
Role of the Funding Source
The study did not receive external funding.
Results
Progress of Implementing the Culture-Based Algorithm
Of the 3 212 421 arrivals of immigrants and refugees between 2007 and 2012, 1 650 961 
(51.4%) were screened by the smear-based algorithm and 1 561 460 (48.6%) were screened 
by the culture-based algorithm. The percentage of persons screened by the culture-based 
algorithm increased from 6.2% in 2007 to 76.2% in 2012 (Figure 1). As a result, the annual 
number of persons identified with class B1 TB by the culture-based algorithm increased 
from 1532 in 2007 to 14 292 in 2012 (Figure 2).
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TB Cases Diagnosed Overseas by the Culture-Based Algorithm
Appendix Tables 1 and 2 (available at www.annals.org) show the results of overseas TB 
screening from 2007 to 2012. Data about TB cases diagnosed overseas by the smear-based 
algorithm were not reported to the CDC. The annual number of TB cases diagnosed 
overseas by the culture-based algorithm increased from 14 in 2007 to 1058 in 2012 (Figure 
3). Among the 1 561 460 persons screened by the culture-based algorithm from 2007 to 
2012, 4032 (258 cases per 100 000 persons) were diagnosed with TB: 751 (48 cases per 100 
000 persons) with smear-positive and culture-positive TB, 606 (39 cases per 100 000 
persons) with smear-positive and culture-negative TB, 2195 (141 cases per 100 000 persons) 
with smear-negative and culture-positive TB, and 480 (31 cases per 100 000 persons) with 
clinically diagnosed TB. Smear-negative and culture-positive TB accounted for 2195 
(54.4%) of the 4032 TB cases diagnosed by the culture-based algorithm.
Between 2007 and 2012, refugees made up only 14.9% of persons screened by the culture-
based algorithm but accounted for 27.4% of TB cases diagnosed overseas among U.S.-
bound immigrants and refugees. Of the 4032 TB cases diagnosed among U.S.-bound 
immigrants and refugees by the culture-based algorithm, 3757 (93.2%) were among persons 
in countries with a WHO-estimated incidence of TB of 100 cases or greater per 100 000 
persons per year. The highest TB prevalence was among persons from Vietnam (890 cases 
per 100 000 persons) and the Philippines (854 cases per 100 000 persons).
Follow-up Evaluation After Arrival in the United States
Appendix Table 3 (available at www.annals.org) shows the results of follow-up evaluation. 
Of the 21 638 persons with class B1 or B2 TB identified by the smear-based algorithm, 11 
686 (54.0%) completed follow-up evaluation in the United States. Among the 60 423 
persons with class B1 TB identified by the culture-based algorithm, 40 896 (67.7%) 
completed follow-up evaluation. For persons who completed follow-up evaluation, active 
TB cases were diagnosed in 410 (3.5%) of the 11 686 persons screened by the smear-based 
algorithm and in 731 (1.8%) of the 40 896 persons screened by the culture-based algorithm 
(P < 0.001). In 2012, 1280 persons were identified with class B1 or B2 TB by the smear-
based algorithm and 14 292 were identified with class B1 TB by the culture-based 
algorithm. If all persons with class B1 or B2 TB completed follow-up evaluation in 2012, 
302 active TB cases were likely diagnosed in the United States (that is, 3.5% of 1280 plus 
1.8% of 14 292).
Class B2 latent TB infection was identified in 41 167 (13.4%) of the 306 084 persons aged 2 
to 14 years in countries with a WHO-estimated incidence of TB 20 cases or greater per 100 
000 persons per year. Of the 41 167 persons with class B2 latent TB infection, 24 090 
(58.5%) completed follow-up evaluation; of these, 79 (0.3%) were diagnosed with active 
TB.
Effect of Implementing the Culture-Based Algorithm
Figure 4 shows the effect of implementing the culture-based algorithm. Before 
implementation (2002 to 2006), the annual number of reported cases among foreign-born 
persons within 1 year after arrival in the United States was relatively constant (range, 1424 
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to 1626 cases; mean, 1504 cases). During the implementation (2007 to 2012), the annual 
number of reported TB cases among foreign-born persons within 1 year after arrival 
decreased from 1511 in 2007 to 940 in 2012. During the same period, the annual number of 
smear-negative and culture-positive TB cases diagnosed overseas among U.S.-bound 
immigrants and refugees by the culture-based algorithm increased from 4 in 2007 to 629 in 
2012. The cumulative decline of reported TB (2231 cases) among foreign-born persons 
within 1 year after arrival during implementation was similar to the total number of cases of 
smear-negative and culture-positive TB in U.S.-bound immigrants and refugees diagnosed 
overseas by the culture-based algorithm (2195 cases) during the same period.
Discussion
In the United States, screening immigrants and refugees for TB has been done for more than 
a century and continues to identify high TB incidence rates (18). Before 2007, the mandated 
overseas TB screening was based on a smear-based algorithm that could not diagnose 
smear-negative and culture-positive TB. In 2007, the CDC revised the smear-based 
algorithm to include the M. tuberculosis culture. From 2007 to 2012, the culture-based 
algorithm was preferentially implemented in countries with a high TB incidence. By 
increasing the number of TB cases diagnosed and treated overseas among U.S.-bound 
immigrants and refugees, the implementation of the culture-based algorithm contributed to 
the decline of foreign-born TB incidence in the United States. In 2012, the culture-based 
algorithm was used to screen 421 734 (76.2%) of the 553 563 U.S.-bound immigrants and 
refugees and diagnosed 1058 TB cases, including 629 cases of smear-negative and culture-
positive TB. If the culture-based algorithm had not been implemented in any countries in 
2012, these 629 smear-negative and culture-positive TB cases would have been imported to 
the United States.
Most TB cases diagnosed among U.S.-bound immigrants and refugees by the culture-based 
algorithm were among persons in countries with a high TB incidence. U.S.-bound refugees 
had a high incidence of TB. Despite only 50 000 to 70 000 annual arrivals, refugees 
contributed substantially to the TB burden among U.S.-bound immigrants and refugees.
In 2012, the U.S. National Tuberculosis Surveillance System reported 940 cases of TB 
among foreign-born persons within 1 year after arrival (16). In 2012, 15 572 immigrants and 
refugees had class B1 or B2 TB. If all of them completed follow-up evaluation after arrival 
in the United States, we estimated that 302 cases of TB would have been diagnosed in 2012. 
These 302 cases of TB estimated among newly arrived immigrants and refugees with class 
B1 or B2 TB accounted for 32.1% of the 940 reported TB cases among foreign-persons 
within 1 year after arrival in the United States. Our findings were consistent with a previous 
study that reported that 38.1% of the 2547 foreign-born TB cases within 1 year after arrival 
between 1992 and 1995 were among immigrants and refugees with class B1 or B2 TB (19). 
Although some of the remaining 638 cases may be among newly arrived immigrants and 
refugees with normal chest radiographs, most could be among new arrivals of nonimmigrant 
visitors and undocumented persons because they were not screened for TB before they 
departed for the United States (20). The CDC provided comprehensive training to panel 
physicians on the culture-based algorithm. This training likely helped panel physicians 
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improve their diagnosis of TB among U.S-bound immigrants and refugees (13). Because of 
the requirement for the M. tuberculosis culture, drug-susceptibility testing, and directly 
observed therapy for TB treatment, the fee for the overseas medical examination increased. 
The U.S. Department of State sponsors refugees, but immigrants pay for their examination 
(5). The fee for immigrant examination is set by the U.S. Consular Sections in each country; 
in many cases, the fee includes the costs of TB treatment. The implementation of the 
culture-based algorithm also increased the CDC’s costs for training, education, and quality 
assurance. A separate study is under way at the CDC to evaluate the cost-effectiveness of 
the culture-based algorithm.
Certain limitations apply to interpreting the results of our analysis. Misclassifications of TB 
cases may occur during overseas screening and follow-up evaluation after arrival. 
Assumptions used for estimating the number of immigrants screened by the culture-based 
algorithm may be invalid. Follow-up data may not be reported randomly to the CDC. In 
2007, the CDC started requiring state and local health departments to enter follow-up 
evaluation data via its newly developed EDN database. The new requirement may have 
affected the follow-up data reported from 2007 to 2008, resulting in a low percentage of 
completion of follow-up evaluation for persons who were screened by the smear-based 
algorithm. We compared the decline of reported TB cases among foreign-born persons 
within 1 year after arrival and the increase of smear-negative and culture-positive TB cases 
diagnosed overseas in U.S.-bound immigrants and refugees by the culture-based algorithm. 
However, this comparison was done without controlling for the decline of new arrivals of 
nonimmigrant visitors to the United States and the decrease of TB incidence in their 
countries of origin. From 2007 to 2012, WHO-estimated incidence of TB decreased globally 
by 10.9%, from 137 cases per 100 000 persons per year in 2007 to 122 cases per 100 000 
persons per year in 2012 (21, 22). The mean of annual admissions of nonimmigrant visitors 
decreased by 8.5%, from 180.9 million between 2002 and 2006 to 165.5 million from 2007 
to 2012 (23–29). However, the mean of the annual number of reported TB cases among 
foreign-born persons within 1 year after arrival decreased 24.7%, from 1504 cases from 
2002 to 2006 to 1132 cases between 2007 and 2012 (14–16).
In 2012, 5334 (85.0%) of the 6274 reported TB cases were among foreign-born persons who 
had been in the United States more than 1 year after their arrival (16). Because 83.7% of the 
foreign-born TB cases in the United States were attributed to reactivation of TB (30), 
identifying and treating latent TB infection is important for eliminating TB in the United 
States (1, 31). In our analysis, prevalence of latent TB infection was 13.5% for U.S.-bound 
immigrants and refugees aged 2 to 14 years in countries with a WHO-estimated TB 
incidence of 20 cases or greater per 100 000 persons per year. In the United States, 11.9% of 
foreign-born persons aged 1 to 14 years had latent TB infection (32). Because shortened 
treatment regimens for latent TB infection have proved to be effective (33–35), cost-
effective and operational research studies are needed to determine ways to address latent TB 
infection screening and treatment in foreign-born persons.
In conclusion, culture-based overseas TB screening is a high-yield intervention for 
preventing TB in U.S.-bound immigrants and refugees. To further reduce the TB incidence 
in foreign-born populations, consideration should be given to expanding TB screening to 
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students, exchange visitors, and temporary workers from countries with a high incidence of 
TB, as well as finding novel strategies to address the large numbers of foreign-born persons 
with latent TB infection.
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U.S.-bound Immigrants and refugees who were screened for TB overseas by the smear-
based algorithm or the culture-based algorithm, 2007–2012
Definitions: TB = Tuberculosis.
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U.S.-bound Immigrants and refugees identified with Class B1 or B2 TB by the smear-based 
algorithm, and those identified with Class B1 TB by the culture-based algortihm, 2007–2012
Definitions: TB = Tuberculosis.
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TB cases diagnosed overseas among 1,561,460 U.S.-bound immigrants and refugees who 
were screened by the culture-based algorithm, 2007–2012
Definitions: TB = Tuberculosis.
* 14 cases of TB diagnosed in 2007: 2 (14.3%) cases of smear-positive/culture-positive TB, 
1 (7.1%) cases of smear-positive/culture-negative TB, 4 (28.6%) cases of smear-negative/
culture-positive TB, and 7 (50.0%) cases of clinically diagnosed TB.
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Comparison of reported TB cases among foreign-born persons within 1 year after arrival in 
the United States and smear-negative/culture-positive TB cases diagnosed overseas among 
U.S.-bound immigrants and refugees by the culture-based algorithm, 2002–2012
Definitions: TB = Tuberculosis.
* Had the culture-based algorithm not been implemented, cases of smear-negative/culture-
positive TB would very likely have been imported to the United States and counted as 
reported cases among foreign-born persons within 1 year after arrival by the U.S. National 
TB Surveillance System.
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Table
TB Classifications Used by the Smear- and Culture-Based Algorithms
TB Classification Smear-Based Algorithm Culture-Based Algorithm
Class A ≥1 sputum smear results were positive. Persons 
diagnosed with class A TB had to complete TB 
treatment overseas and would be reclassified as 
having class B2 TB.
≥1 sputum smear or culture results were positive or TB was 
clinically diagnosed. Persons diagnosed with class A TB had 
to complete directly observed therapy for TB overseas and 
would be reclassified as having class B1 TB.
Class A TB waiver: Persons with class A TB received 
TB treatment overseas until their sputum smear 
results became negative and applied for an 
immigration waiver. A class A TB waiver is rare. 
Follow-up evaluation after arrival in the United States 
is mandated for persons with a class A TB waiver.
Class A TB waiver: Persons with class A TB received 
directly observed therapy until their sputum smear and 
culture results became negative and applied for an 
immigration waiver. A class A TB waiver is rare. Follow-up 
evaluation after arrival in the United States is mandated for 
persons with a class A TB waiver.
Class B1 Chest radiograph suggestive of active TB Chest radiograph, medical history, or examination suggestive 
of TB
Class B2 Chest radiograph suggestive of inactive TB NA
Class B2 latent TB 
infection
NA Induration of ≥ 10 mm on TST or positive results on an 
IGRA
No TB Normal chest radiograph Normal chest radiograph
IGRA = interferon-γ release assay; NA = not applicable; TB = tuberculosis; TST = tuberculin skin test.
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